CAFs derived from patients with colorectal cancer express EGFR,29 suggesting that NIR‐PIT using cetuximab‐IR700 conjugates currently used in clinical practice may eliminate cancer and stroma cells simultaneously regardless of whether they are senescent or not. This evidence concerns the gene EGFR and colorectal cancer.